TR200003084T2 - Paroxetine askorbat - Google Patents
Paroxetine askorbatInfo
- Publication number
- TR200003084T2 TR200003084T2 TR2000/03084T TR200003084T TR200003084T2 TR 200003084 T2 TR200003084 T2 TR 200003084T2 TR 2000/03084 T TR2000/03084 T TR 2000/03084T TR 200003084 T TR200003084 T TR 200003084T TR 200003084 T2 TR200003084 T2 TR 200003084T2
- Authority
- TR
- Turkey
- Prior art keywords
- paroxetine ascorbate
- paroxetine
- ascorbate
- useful
- treatment
- Prior art date
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title abstract 4
- AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title abstract 2
- AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title abstract 2
- 229940072107 ascorbate Drugs 0.000 title abstract 2
- 235000010323 ascorbic acid Nutrition 0.000 title abstract 2
- 239000011668 ascorbic acid Substances 0.000 title abstract 2
- 229960002296 paroxetine Drugs 0.000 title abstract 2
- 208000015114 central nervous system disease Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Paroxetine askorbat, bazi CNS hastaliklarinin tedavisinde faydalidir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200003084T2 true TR200003084T2 (tr) | 2001-02-21 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/03084T TR200003084T2 (tr) | 1998-04-25 | 1999-04-23 | Paroxetine askorbat |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (tr) |
| JP (1) | JP2002513019A (tr) |
| KR (1) | KR20010042977A (tr) |
| CN (1) | CN1297448A (tr) |
| AP (1) | AP2000001963A0 (tr) |
| AU (1) | AU3618499A (tr) |
| BG (1) | BG104940A (tr) |
| BR (1) | BR9909868A (tr) |
| CA (1) | CA2330055A1 (tr) |
| EA (1) | EA200001104A1 (tr) |
| GB (1) | GB9808896D0 (tr) |
| HU (1) | HUP0102116A3 (tr) |
| ID (2) | ID26654A (tr) |
| IL (1) | IL139081A0 (tr) |
| NO (1) | NO20005352L (tr) |
| PL (1) | PL343677A1 (tr) |
| SK (1) | SK15912000A3 (tr) |
| TR (1) | TR200003084T2 (tr) |
| WO (1) | WO1999055698A1 (tr) |
| ZA (1) | ZA200005912B (tr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| CA2471144C (en) | 2002-01-09 | 2011-06-07 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| CN110607553B (zh) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Withdrawn
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Ceased
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/tr unknown
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352L/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1297448A (zh) | 2001-05-30 |
| AU3618499A (en) | 1999-11-16 |
| AP2000001963A0 (en) | 2000-12-31 |
| BR9909868A (pt) | 2000-12-19 |
| CA2330055A1 (en) | 1999-11-04 |
| ID26654A (id) | 2001-01-25 |
| WO1999055698A1 (en) | 1999-11-04 |
| EA200001104A1 (ru) | 2001-04-23 |
| GB9808896D0 (en) | 1998-06-24 |
| IL139081A0 (en) | 2001-11-25 |
| BG104940A (bg) | 2001-09-28 |
| HUP0102116A3 (en) | 2002-12-28 |
| KR20010042977A (ko) | 2001-05-25 |
| NO20005352D0 (no) | 2000-10-24 |
| EP1089995A1 (en) | 2001-04-11 |
| PL343677A1 (en) | 2001-08-27 |
| JP2002513019A (ja) | 2002-05-08 |
| SK15912000A3 (sk) | 2001-04-09 |
| NO20005352L (no) | 2000-10-24 |
| ID26083A (id) | 2000-11-23 |
| ZA200005912B (en) | 2001-12-19 |
| HUP0102116A2 (hu) | 2002-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60022692D1 (de) | (S,S)-Reboxetin zur Behandlung von Migränekopfschmerzen | |
| TR200000059T2 (tr) | Piridin türevleri | |
| ID26043A (id) | Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv | |
| DE60010098D1 (de) | 28-epirapaloge | |
| DE69925306D1 (de) | Behandlung von kohlenwasserstoffgas | |
| PT1140944E (pt) | Derivados de epotilona e sua utilizacao como agentes antitumorais | |
| ATE350044T1 (de) | Thrombopoietinmimetika | |
| BR9707233A (pt) | Fenantridinas | |
| ES2184077T3 (es) | Nuevas fenantridinas sustituidas en la posicion 6. | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| DE60025632D1 (de) | Thrombopoietin-mimetika | |
| DE69919700D1 (de) | Überbrückte indenopyrrolocarbazole | |
| DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
| PT1204659E (pt) | Benzofuranos serotoninergicos | |
| CY1107039T1 (el) | Αναστολεις τριπεπτιδυλ πεπτιδασης | |
| TR200200278T2 (tr) | Kalsilitik bileşimler | |
| TR200003084T2 (tr) | Paroxetine askorbat | |
| NO20005548D0 (no) | Mykobakterieinhibitorer | |
| TR200002939T2 (tr) | Paroksetin maleat | |
| ES2185605T3 (es) | 2,3-dihidro-1h-5,9-dioxaciclohepta (f) inden-7-onas 1,2-sustituidas y benzo (b) (1,4)dioxepin-3 onas 7-sustituidas. | |
| TR200003083T2 (tr) | CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate. | |
| NO20021429L (no) | 1,4-dioksacykloalkan-2-oner og 1,4-dioksacykloalken-2-oner | |
| PT1017377E (pt) | Utilizacao de 2-aminotetralinas 6,7-substituidas para o tratamento de condicoes inflamatorias mediadas por citoquina | |
| DK1133297T3 (da) | Ny terapeutisk anvendelse af 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergolin | |
| IT1305242B1 (it) | Preparatore di mazzi di pelli. |